2018 Announcements

Chair Letter to Shareholders

05 October 2018

This is a thank you to shareholders, investors, patients, clinicians, and all those who have continued to support CLINUVEL together with new shareholders who have recently gained confidence to join the CLINUVEL register. The Company’s performance of the past years, the first ever dividend declared, and progress towards US market entry are some of the main motivations to support the Company’s course at this point in time.

Download PDF for more

Go To Top